[Verification of the dose delivered to the patient by means of TLD, SC, PID. What future?].
Among the different possibilities to check the accuracy of the treatment delivered, only in vivo dosimetry ensures the precision of the dose delivered to the patient during the treatment. In 1970-1980, Ruden assessed the use of thermoluminescent dosimetry to perform in vivo measurements at Radiumemmet in Stockholm. Straightforward in its principle but demanding in its implementation, thermoluminescent dosimetry has largely been used. Today, thanks to the work of Rikner, the use of semiconductor detectors allows the general implementation of in vivo dosimetry. Tomorrow, we will use electronic portal imaging device to verify the geometrical patient setup and the dose delivery at the same time. Its implementation remains complex and will need the development of algorithms to compute exit dose or midplane dose using portal in vivo dosimetry. First clinical results show that portal imaging is an accurate alternative for conventional in vivo dosimetry using diodes.
Noël
A
A
Centre Alexis-Vautrin, unité de radiophysique médicale, avenue de Bourgogne, 54500 Vandaeuvre-Lès-Nancy, France. a.noel@nancy.fnclcc.fr
D000465:Algorithms; D005544:Forecasting; D006801:Humans; D011785:Quality Assurance, Health Care; D011874:Radiometry / Q000295:instrumentation*; D011878:Radiotherapy / Q000592:standards*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D012666:Semiconductors; D013819:Thermoluminescent Dosimetry